{"id":484037,"date":"2021-04-29T07:05:18","date_gmt":"2021-04-29T11:05:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/"},"modified":"2021-04-29T07:05:18","modified_gmt":"2021-04-29T11:05:18","slug":"hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/","title":{"rendered":"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK and VIENNA, Austria, April  29, 2021  (GLOBE NEWSWIRE) &#8212; HOOKIPA Pharma Inc. (NASDAQ: HOOK, \u2018HOOKIPA\u2019), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA\u2019s management team will participate and present at the following upcoming virtual investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>7th Annual Truist Securities Life Sciences Summit, May 4 \u2013 5, 2021<br \/><\/strong><br \/>\n          <strong>Fireside Chat: <\/strong>May 4, 1:50pm ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Bank of America 2021 Health Care Conference, May 10 \u2013 13, 2021<br \/><\/strong><br \/>\n          <strong>Presentation: <\/strong>May 13, 1:15pm ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Morgan Stanley Virtual Asia Healthcare Conference, May 13 &#8211; 14, 2021<\/strong><\/p>\n<\/li>\n<li>\n          <strong>RBC Capital Markets Global Healthcare Conference, May 18 &#8211; 20, 2021<br \/><\/strong><br \/>\n          <strong>Fireside Chat: <\/strong>May 18, 9:45am ET<\/li>\n<\/ul>\n<p align=\"justify\">The live audio webcasts of the fireside chats and presentation will be available within the Investors &amp; Media section of HOOKIPA\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4iomIsGwKPdhzu2Gm1DcR-Xa9L-bqKzRSuTpMXK93p9mXz1M9cgvPm4k5saL_qtTQ1AYavBYcOL5aJsbwTncJGDCLIyVx-emhRYfKtMBMd6f4H3HjcVDr2WGIzX9u1Rt\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.hookipapharma.com\/events<\/a>. An archived replay will be accessible for 30 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About HOOKIPA<\/strong><br \/>\n        <br \/>HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on its proprietary arenavirus platform that reprograms the body\u2019s immune system.<\/p>\n<p align=\"justify\">HOOKIPA\u2019s proprietary arenavirus-based technologies, non-replicating and replicating, induce robust antigen-specific CD8+\u00a0T cells and pathogen-neutralizing antibodies. HOOKIPA\u2019s viral vectors target antigen presenting cells in vivo to activate the immune system. Both technologies enable repeat administration to augment and refresh immune responses. As a monotherapy not used in combination, our replicating arenavirus technology has the potential to induce CD8+\u00a0T cell response levels previously not achieved by other immuno-therapy approaches.<\/p>\n<p align=\"justify\">HOOKIPA is building a proprietary immuno-oncology pipeline by targeting virally mediated cancer antigens, self-antigens and next-generation antigens. The lead replicating arenavirus oncology product candidates, HB-201 and HB-202, are in development for the treatment of Human Papilloma Virus 16-positive cancers in a Phase 1\/2 clinical trial.<\/p>\n<p align=\"justify\">HOOKIPA\u2019s non-replicating prophylactic Cytomegalovirus (CMV) vaccine candidate, HB-101, is currently in a Phase 2 clinical trial for patients awaiting kidney transplantation. To expand its infectious disease portfolio, HOOKIPA entered into a collaboration and licensing agreement with Gilead Sciences, Inc. to research arenavirus-based functional cures for HIV and chronic Hepatitis B infections.<\/p>\n<p align=\"justify\">Find out more about HOOKIPA online at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4FdFi-soqZNOSAVxmKOytxQ18hWe50f1QkhnmQcpT-Lq8EmgyRJ8rYEw7EATEjdqv6Rr17pkXpI8EWBCFf0zxmtI2waElnv-0HNz6KIENZc=\" rel=\"nofollow noopener\" target=\"_blank\">www.hookipapharma.com<\/a>.<\/p>\n<p>For further information, please contact:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:25%;width:25%;min-width:25%\">\n            <strong>Media<\/strong>\n          <\/td>\n<td style=\"max-width:75%;width:75%;min-width:75%\">\n            <strong>Investors<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Nina Waibel<\/td>\n<td>Matt Beck<\/td>\n<\/tr>\n<tr>\n<td>Senior Director &#8211; Communications<\/td>\n<td>Executive Director &#8211; Investor Relations<\/td>\n<\/tr>\n<tr>\n<td>\n            <a href=\"mailto:nina.waibel@hookipapharma.com\" rel=\"nofollow noopener\" target=\"_blank\">nina.waibel@hookipapharma.com<\/a>\n          <\/td>\n<td>\n            <a href=\"mailto:matthew.beck@hookipapharma.com\" rel=\"nofollow noopener\" target=\"_blank\">matthew.beck@hookipapharma.com<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ce5b31c1-cd63-4458-bb3c-91dbaaf5b0d4\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and VIENNA, Austria, April 29, 2021 (GLOBE NEWSWIRE) &#8212; HOOKIPA Pharma Inc. (NASDAQ: HOOK, \u2018HOOKIPA\u2019), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA\u2019s management team will participate and present at the following upcoming virtual investor conferences: 7th Annual Truist Securities Life Sciences Summit, May 4 \u2013 5, 2021 Fireside Chat: May 4, 1:50pm ET Bank of America 2021 Health Care Conference, May 10 \u2013 13, 2021 Presentation: May 13, 1:15pm ET Morgan Stanley Virtual Asia Healthcare Conference, May 13 &#8211; 14, 2021 RBC Capital Markets Global Healthcare Conference, May 18 &#8211; 20, 2021 Fireside Chat: May 18, 9:45am ET The live audio webcasts of the fireside chats and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-484037","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and VIENNA, Austria, April 29, 2021 (GLOBE NEWSWIRE) &#8212; HOOKIPA Pharma Inc. (NASDAQ: HOOK, \u2018HOOKIPA\u2019), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA\u2019s management team will participate and present at the following upcoming virtual investor conferences: 7th Annual Truist Securities Life Sciences Summit, May 4 \u2013 5, 2021 Fireside Chat: May 4, 1:50pm ET Bank of America 2021 Health Care Conference, May 10 \u2013 13, 2021 Presentation: May 13, 1:15pm ET Morgan Stanley Virtual Asia Healthcare Conference, May 13 &#8211; 14, 2021 RBC Capital Markets Global Healthcare Conference, May 18 &#8211; 20, 2021 Fireside Chat: May 18, 9:45am ET The live audio webcasts of the fireside chats and &hellip; Continue reading &quot;HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T11:05:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May\",\"datePublished\":\"2021-04-29T11:05:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/\"},\"wordCount\":377,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/\",\"name\":\"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=\",\"datePublished\":\"2021-04-29T11:05:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/","og_locale":"en_US","og_type":"article","og_title":"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May - Market Newsdesk","og_description":"NEW YORK and VIENNA, Austria, April 29, 2021 (GLOBE NEWSWIRE) &#8212; HOOKIPA Pharma Inc. (NASDAQ: HOOK, \u2018HOOKIPA\u2019), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA\u2019s management team will participate and present at the following upcoming virtual investor conferences: 7th Annual Truist Securities Life Sciences Summit, May 4 \u2013 5, 2021 Fireside Chat: May 4, 1:50pm ET Bank of America 2021 Health Care Conference, May 10 \u2013 13, 2021 Presentation: May 13, 1:15pm ET Morgan Stanley Virtual Asia Healthcare Conference, May 13 &#8211; 14, 2021 RBC Capital Markets Global Healthcare Conference, May 18 &#8211; 20, 2021 Fireside Chat: May 18, 9:45am ET The live audio webcasts of the fireside chats and &hellip; Continue reading \"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-29T11:05:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May","datePublished":"2021-04-29T11:05:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/"},"wordCount":377,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/","name":"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=","datePublished":"2021-04-29T11:05:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjM4NSM0MTQ2NDU3IzIxNTY5MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-may\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=484037"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484037\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=484037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=484037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=484037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}